Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TORIPALIMAB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where TORIPALIMAB was used for Neoplasm.

Most Reported Side Effects for TORIPALIMAB

Side Effect Reports % Deaths Hosp.
Myelosuppression 590 43.9% 3 432
Off label use 276 20.5% 29 137
White blood cell count decreased 144 10.7% 0 74
Anaemia 67 5.0% 17 8
Hypothyroidism 67 5.0% 13 11
Neutrophil count decreased 67 5.0% 0 25
Nausea 60 4.5% 7 14
Rash 59 4.4% 7 11
Vomiting 58 4.3% 7 14
Platelet count decreased 53 3.9% 3 30
Diarrhoea 50 3.7% 6 16
Neutropenia 49 3.7% 8 1
Thrombocytopenia 48 3.6% 12 0
Pyrexia 46 3.4% 2 13
Decreased appetite 43 3.2% 9 9

Other Indications for TORIPALIMAB

Nasopharyngeal cancer (163) Hepatocellular carcinoma (125) Oesophageal carcinoma (72) Lung neoplasm malignant (65) Breast cancer (40) Malignant melanoma (36) Small cell lung cancer (36) Hepatic cancer (34) Renal cancer (34) Bladder cancer (33)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

TORIPALIMAB Full Profile All Neoplasm Drugs TORIPALIMAB Demographics TORIPALIMAB Timeline